Joseph J. Skitzki - Concepedia

Author

Joseph J. Skitzki

Roswell Park Comprehensive Cancer Center ORCID

Also Known As

April K Salama, J Skitzki, J. J. Skitzki, J. Skitzki, J.J. Skitzki, JOSEPH J. SKITZKI, Joseph J Skitzki, Joseph J. Skitzki, Joseph Skitzki, Y Shargall

130

Publications

4.1K

Citations

H-Index

Concepts

All Affiliations

Roswell Park Comprehensive Cancer Center Massachusetts General Hospital University of Michigan Memorial Sloan Kettering Cancer Center The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute

About

Joseph J. Skitzki is an author at Roswell Park Comprehensive Cancer Center specializing in medicine, oncology, and cancer research.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	15	16	1.7K
2	Cell Biology	5	5	234
3	Health Sciences	2	2	637
4	Public Health	1	1	18
5	Cellular Therapies	1	1	18

Joseph J. Skitzki

Publications

3.1K

Citations

H-Index

Page 1

	Year	Citations
Non-redundant requirement for CXCR3 signalling during tumoricidal T-cell trafficking across tumour vascular checkpoints Maryann Mikucki, Daniel T. Fisher, Junko Matsuzaki, Nature Communications	2015	484
Cutaneous Melanoma, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology Daniel G. Coit, John A. Thompson, Mark R. Albertini, Journal of the National Comprehensive Cancer Network Tumor BiologySurgical OncologyBraf-targeted TherapyMedicineMelanoma	2019	432
NCCN Guidelines® Insights: Melanoma: Cutaneous, Version 2.2021 Susan M. Swetter, John A. Thompson, Mark R. Albertini, Journal of the National Comprehensive Cancer Network Nccn Guidelines® InsightsSurgical OncologyNccn Guidelines InsightsPathologyDermatology	2021	327
Melanoma, Version 2.2016, NCCN Clinical Practice Guidelines in Oncology Daniel G. Coit, John A. Thompson, Alain P. Algazi, Journal of the National Comprehensive Cancer Network Surgical OncologyHigh-dose IpilimumabCancer ManagementImmunologyImmunotherapeutics	2016	310
IL-6 trans-signaling licenses mouse and human tumor microvascular gateways for trafficking of cytotoxic T cells Daniel T. Fisher, Qing Chen, Joseph J. Skitzki, Journal of Clinical Investigation	2011	225
Central role of liver in anticancer and radioprotective activities of Toll-like receptor 5 agonist Lyudmila G. Burdelya, Craig M. Brackett, Bojidar Kojouharov, Proceedings of the National Academy of Sciences	2013	120
Systemic Therapy in Advanced Cutaneous Squamous Cell Carcinoma (CSCC) Anthony Jarkowski, Ryan Hare, Peter Loud, American Journal of Clinical Oncology	2014	112
Tumor-induced MDSC act via remote control to inhibit L-selectin-dependent adaptive immunity in lymph nodes Amy Ku, Jason B. Muhitch, Colin Powers, eLife T-regulatory CellImmunologyImmunotherapyTumor BiologyRemote Control	2016	109
NCCN Guidelines Insights: Melanoma, Version 3.2016 Daniel G. Coit, John A. Thompson, Alain P. Algazi, Journal of the National Comprehensive Cancer Network Surgical OncologySkin CancerMedicineMelanomaNccn Guidelines Insights	2016	100
NCCN Guidelines® Insights: Melanoma: Cutaneous, Version 2.2024 Susan M. Swetter, Douglas B. Johnson, Mark R. Albertini, Journal of the National Comprehensive Cancer Network Nccn Guidelines® InsightsSurgical OncologyNccn PanelMedicineMelanoma	2024	100

Page 1